EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Public ClinicalTrials.gov record NCT04437368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
EXPLORE: A Phase II, Outcomes Assessor-masked, Multicentre, Randomised Study to Evaluate the Safety and Efficacy of Two Doses of GT005 Administered as a Single Subretinal Injection in Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical study was to evaluate the safety and efficacy of two doses of GT005 administered as a single subretinal injection in subjects with geographic atrophy secondary to age-related macular degeneration (AMD).
Study identification
- NCT ID
- NCT04437368
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 98 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 55 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 25, 2019
- Primary completion
- Apr 4, 2024
- Completion
- Apr 4, 2024
- Last update posted
- Jan 26, 2026
2019 – 2024
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retinal Research Institute (retina consultants of AZ) | Phoenix | Arizona | 85053 | — |
| Retina Associates of Southern California | Huntington Beach | California | 92647 | — |
| Byers Eye Institute at Stanford | Palo Alto | California | 94303 | — |
| Retina Consultants San Diego | Poway | California | 92064 | — |
| VitreoRetinal Associates, P.A. | Gainesville | Florida | 32607 | — |
| Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| Retina Vitreous Associates of Florida | St. Petersburg | Florida | 33711 | — |
| Southeast Retina Center | Augusta | Georgia | 30909 | — |
| University Retina Macula Associates PC | Lemont | Illinois | 60439 | — |
| Midwest Eye Institute Northside | Indianapolis | Indiana | 46290 | — |
| Wolfe Eye Clinic | West Des Moines | Iowa | 50266 | — |
| The Retina Care Center | Baltimore | Maryland | 21209 | — |
| Ophthalmic Consultants of Boston (OCB) | Boston | Massachusetts | 02114 | — |
| VitreoRetinal Surgery, PLLC | Minneapolis | Minnesota | 55435 | — |
| Sierra Eye Associates | Reno | Nevada | 89502 | — |
| Vision Research Center Eye Associates of New Mexico | Albuquerque | New Mexico | 87109 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Retina Associates of Western New York | Rochester | New York | 14620 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Retina | Eugene | Oregon | 97401 | — |
| Casey Eye Institute | Portland | Oregon | 97239 | — |
| Erie Retinal Surgery, INC | Erie | Pennsylvania | 16507 | — |
| Mid Atlantic Retina | Philadelphia | Pennsylvania | 19107 | — |
| Southeastern Retina Associates, PC | Knoxville | Tennessee | 37922 | — |
| Charles Retina Institute | Memphis | Tennessee | 38138 | — |
| Austin Research Center for Retina, PLLC | Austin | Texas | 78705 | — |
| Retina Consultants of Houston-TMC | Bellaire | Texas | 77401 | — |
| Texas Retina Associates | Dallas | Texas | 75231 | — |
| Retinal Consultants of San Antonio | San Antonio | Texas | 78240 | — |
| Department of Ophthalmology UW Medicine | Seattle | Washington | 98104-2499 | — |
| West Virginia University | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
Recently updated Dry Age-related Macular Degeneration trials
Other public records listing Dry Age-related Macular Degeneration. Sorted by last update posted; newest first. Not a recommendation.
- NCT07770828: Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD Recruiting
- NCT07680244: (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000 Recruiting
- NCT04339764: Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration Recruiting
- NCT03392324: PRIMA US-Feasibility Study in Atrophic Dry AMD Active, not recruiting
- NCT06557460: A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy) Recruiting
- NCT04627428: Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04437368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04437368 live on ClinicalTrials.gov.